Compare IMAX & PAHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IMAX | PAHC |
|---|---|---|
| Founded | 1967 | 1946 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 1997 | 2014 |
| Metric | IMAX | PAHC |
|---|---|---|
| Price | $35.78 | $58.15 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 4 |
| Target Price | ★ $44.50 | $41.25 |
| AVG Volume (30 Days) | ★ 1.1M | 222.4K |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.91% |
| EPS Growth | 31.25 | ★ 1883.33 |
| EPS | 0.07 | ★ 1.32 |
| Revenue | $410,212,000.00 | ★ $833,350,000.00 |
| Revenue This Year | $9.79 | $17.03 |
| Revenue Next Year | $7.51 | $3.82 |
| P/E Ratio | $511.86 | ★ $42.75 |
| Revenue Growth | ★ 16.47 | 4.12 |
| 52 Week Low | $24.20 | $19.17 |
| 52 Week High | $43.16 | $60.08 |
| Indicator | IMAX | PAHC |
|---|---|---|
| Relative Strength Index (RSI) | 42.24 | 58.87 |
| Support Level | $33.64 | $50.84 |
| Resistance Level | $37.52 | $60.08 |
| Average True Range (ATR) | 1.50 | 2.47 |
| MACD | -0.07 | 0.04 |
| Stochastic Oscillator | 36.77 | 94.66 |
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.
Phibro Animal Health Corp operates as a diversified animal health and mineral nutrition company. It develops, manufactures, and markets products for a range of food animals comprising poultry, swine, beef and dairy cattle, and aquaculture. The product portfolio of the company includes animal health products such as antibacterials, anticoccidials, nutritional specialty products and vaccines, and mineral nutrition products. The company operates through three segments, Animal Health, Mineral Nutrition, and Performance Products, of which key revenue is derived from the Animal Health segment which relates to the development, manufacturing, and marketing of antibacterials, nutritional specialty products, and vaccines. The entity sells its products in the U.S. and other international countries.